Class Action Lawsuits Filed: Are Your Investments at Risk?

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a leading shareholder rights law firm, has announced that class actions have been commenced on behalf of stockholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR), Metagenomi, Inc. (NASDAQ: MGX), and New Fortress Energy Inc. (NASDAQ:NFE). This development has significant implications for investors who have seen the value of their shares potentially impacted by the actions of these companies.

Allarity Therapeutics, Inc. (NASDAQ: ALLR)

Allarity Therapeutics, Inc. is a biopharmaceutical company that focuses on the development and commercialization of personalized cancer treatments. However, the recent class action lawsuit filed against the company raises concerns about the accuracy of its financial reporting and the potential consequences for investors. If you purchased or otherwise acquired Allarity Therapeutics securities during the relevant period, you may be entitled to compensation.

Metagenomi, Inc. (NASDAQ: MGX)

Metagenomi is a biotechnology company that specializes in gene editing and gene regulation. The company has been at the forefront of innovation in this area; however, the filing of a class action lawsuit suggests that there may be issues with the company's financial disclosures that could affect its stock performance. If you have an investment in Metagenomi and are concerned about the impact of this lawsuit on your shares, now is the time to seek advice.

New Fortress Energy Inc. (NASDAQ:NFE)

New Fortress Energy is a global energy infrastructure company that aims to accelerate the world's transition to clean energy. Despite its promising vision, the company has found itself the subject of a class action lawsuit related to its financial reporting practices. If you invested in New Fortress Energy and are seeking to understand your options, contacting Bragar Eagel & Squire, P.C. may be the first step towards potential compensation or other remedies.

Important Deadlines and How to Proceed

Investors in these companies need to be aware of the relevant deadlines for petitioning the court to serve as lead plaintiff in these class actions. Under the law, lead plaintiffs can lead the class action in the courtroom and work closely with the attorneys on behalf of the class. By taking this step, eligible investors can potentially influence the direction of the case and any resulting compensation or other forms of relief.

Shareholders in Allarity Therapeutics, Metagenomi, and New Fortress Energy should take immediate action if they wish to protect their rights. This involves reaching out to a reputable law firm such as Bragar Eagel & Squire, P.C., which has extensive experience in managing class action lawsuits related to shareholder rights and corporate malfeasance.

Contacting Bragar Eagel & Squire, P.C.

If you purchased shares in Allarity Therapeutics, Inc., Metagenomi, Inc., or New Fortress Energy Inc. and would like more information on the status of the class action lawsuits or need guidance on the next steps to protect your investments, you can contact Bragar Eagel & Squire, P.C. through their website. By leveraging their expertise in shareholder rights, you can potentially navigate the complexities of these cases more effectively.